share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:拟议出售证券
美股sec公告 ·  04/16 10:45
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/16/2024, as per the latest filing. These shares, valued at an aggregate market value of $3,729.92, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered. This planned sale follows a significant transaction history over the past few months, where a total of 249,984 shares were sold by the officer, generating total gross proceeds of $306,607.36. The notice of the upcoming sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/16/2024, as per the latest filing. These shares, valued at an aggregate market value of $3,729.92, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered. This planned sale follows a significant transaction history over the past few months, where a total of 249,984 shares were sold by the officer, generating total gross proceeds of $306,607.36. The notice of the upcoming sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
最新文件显示,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月16日出售该公司的3,968股A类股票。这些股票的总市值为3,729.92美元,最初是在2022年7月10日作为限制性股票归属的一部分收购的,是对所提供服务的补偿。此次计划出售遵循了过去几个月的重大交易记录,该高管共出售了249,984股股票,总收益为306,607.36美元。即将进行的出售通知是在出售的同一天提交的,该交易的计划已于2023年3月14日通过。
最新文件显示,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月16日出售该公司的3,968股A类股票。这些股票的总市值为3,729.92美元,最初是在2022年7月10日作为限制性股票归属的一部分收购的,是对所提供服务的补偿。此次计划出售遵循了过去几个月的重大交易记录,该高管共出售了249,984股股票,总收益为306,607.36美元。即将进行的出售通知是在出售的同一天提交的,该交易的计划已于2023年3月14日通过。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息